Published in Biol Blood Marrow Transplant on August 03, 2010
The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care. Cytotherapy (2014) 1.03
Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation. Cytotherapy (2012) 1.01
Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry. Front Immunol (2013) 0.90
Controlling cytomegalovirus: helping the immune system take the lead. Viruses (2014) 0.89
Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice. PLoS Pathog (2015) 0.78
Broad spectrum antiviral T cells for viral complications after hematopoietic stem cell transplantation. Ann Transl Med (2015) 0.78
Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation. J Immunol Res (2014) 0.77
CMV in Hematopoietic Stem Cell Transplantation. Mediterr J Hematol Infect Dis (2016) 0.75
The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide. Bone Marrow Transplant (2016) 0.75
Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med (2011) 6.79
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant (2009) 5.10
Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA (2010) 4.21
Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med (2005) 3.97
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet (2011) 3.41
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet (2010) 3.15
A multibiomarker-based outcome risk stratification model for adult septic shock*. Crit Care Med (2014) 2.94
Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood (2004) 2.83
Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: implications for the peopling of South Asia. Am J Hum Genet (2004) 2.73
The circumplex model of affect: an integrative approach to affective neuroscience, cognitive development, and psychopathology. Dev Psychopathol (2005) 2.64
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med (2008) 2.64
Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis. Thromb Haemost (2003) 2.59
Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology (2002) 2.59
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis (2009) 2.59
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ (2011) 2.50
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol (2009) 2.48
Effects of school closure on incidence of pandemic influenza in Alberta, Canada. Ann Intern Med (2012) 2.42
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood (2008) 2.35
Swine outbreak of pandemic influenza A virus on a Canadian research farm supports human-to-swine transmission. Clin Infect Dis (2011) 2.28
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care (2004) 2.25
Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med (2014) 2.19
Thermomechanics of the shape memory effect in polymers for biomedical applications. J Biomed Mater Res A (2005) 2.17
The dazzling array of basal branches in the mtDNA macrohaplogroup M from India as inferred from complete genomes. Mol Biol Evol (2005) 2.03
Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res (2003) 2.01
Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med (2005) 1.99
Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell (2012) 1.98
Neural systems subserving valence and arousal during the experience of induced emotions. Emotion (2010) 1.97
Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med (2014) 1.97
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS. Biol Blood Marrow Transplant (2008) 1.96
Clinical service organisation for heart failure. Cochrane Database Syst Rev (2012) 1.90
Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. J Clin Microbiol (2009) 1.76
Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol (2004) 1.74
Severity of illness and risk of death associated with pulmonary artery catheter use. Crit Care Med (2004) 1.72
SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS One (2011) 1.70
Comparison of the Luminex xTAG respiratory viral panel with xTAG respiratory viral panel fast for diagnosis of respiratory virus infections. J Clin Microbiol (2011) 1.68
Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. Biol Blood Marrow Transplant (2008) 1.67
A prospective clinical study of proximal humerus fractures treated with a locking proximal humerus plate. J Orthop Trauma (2011) 1.66
Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation. Pediatr Res (2005) 1.66
Protein C -1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis. Crit Care Med (2007) 1.63
Analysis of spatial and temporal water pollution patterns in Lake Dianchi using multivariate statistical methods. Environ Monit Assess (2009) 1.62
Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning. Blood (2003) 1.61
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis (2012) 1.58
Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome. Ann Neurol (2003) 1.57
Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells. Circ Res (2007) 1.54
Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Crit Care Med (2011) 1.54
Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med (2006) 1.54
A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock. Am J Respir Crit Care Med (2014) 1.53
Agreement in electrocardiogram interpretation in patients with septic shock. Crit Care Med (2011) 1.52
Albumin resuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia. Crit Care Med (2003) 1.51
Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial. Biol Blood Marrow Transplant (2013) 1.51
Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day. Chest (2003) 1.50
Immune reconstitution after hematopoietic cell transplantation. Curr Opin Hematol (2012) 1.48
SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data. Genome Biol (2013) 1.47
High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen. Biol Blood Marrow Transplant (2008) 1.46
Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine. Crit Care (2013) 1.46
Albumin resuscitation improves ventricular contractility and myocardial tissue oxygenation in rat endotoxemia. Crit Care Med (2007) 1.45
Longitudinal study of influenza molecular viral shedding in Hutterite communities. J Infect Dis (2012) 1.45
A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome. Crit Care Med (2008) 1.44
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44
Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock. Crit Care Med (2014) 1.44
The neurophysiological bases of emotion: An fMRI study of the affective circumplex using emotion-denoting words. Hum Brain Mapp (2009) 1.44
Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest (2003) 1.43
Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res (2007) 1.43
Effect of airborne contaminants on the wettability of supported graphene and graphite. Nat Mater (2013) 1.42
Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol (2008) 1.42
Monodisperse porous LiFePO4 microspheres for a high power Li-ion battery cathode. J Am Chem Soc (2011) 1.41
Letter to the editor: another treatment choice for subdural effusion with ventricle dilation. Acta Neurochir (Wien) (2015) 1.38
Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.38
Anal HPV infection in HIV-positive men who have sex with men from China. PLoS One (2010) 1.37
A closer look at preschoolers' freely produced labels for facial expressions. Dev Psychol (2003) 1.37
Pulmonary hemodynamics in neonatal lambs resuscitated with 21%, 50%, and 100% oxygen. Pediatr Res (2007) 1.36
The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans. Dev Biol (2008) 1.36
Language and the perception of emotion. Emotion (2006) 1.35
The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med (2009) 1.34
Hierarchical Aligned Cluster Analysis for Temporal Clustering of Human Motion. IEEE Trans Pattern Anal Mach Intell (2012) 1.31
Community-based survey of HIV transmission modes among intravenous drug users in Sichuan, China. Sex Transm Dis (2004) 1.31
The association of sport performance with ACE and ACTN3 genetic polymorphisms: a systematic review and meta-analysis. PLoS One (2013) 1.29
Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng (2005) 1.28
Full-genome analysis of avian influenza A(H5N1) virus from a human, North America, 2013. Emerg Infect Dis (2014) 1.27
Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Biol Blood Marrow Transplant (2007) 1.26
HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China. J Acquir Immune Defic Syndr (2005) 1.26
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood (2002) 1.26
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood (2003) 1.25
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Exp Hematol (2003) 1.25
Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care (2012) 1.24
Bioinspired catecholic chemistry for surface modification. Chem Soc Rev (2011) 1.24
Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis (2014) 1.23
IL17A genetic variation is associated with altered susceptibility to Gram-positive infection and mortality of severe sepsis. Crit Care (2011) 1.23
miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Mol Med Rep (2011) 1.23
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma. Blood (2010) 1.23
Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J Immunol (2005) 1.21
Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer. Bioorg Med Chem Lett (2011) 1.20
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin. Biol Blood Marrow Transplant (2007) 1.20